Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Human papillomavirus 6/11 vaccine recombinant bivalent - Xiamen Innovax

Next Previous
Search
Drug Profile

Human papillomavirus 6/11 vaccine recombinant bivalent - Xiamen Innovax

Alternative Names: Gecolin; Human papillomavirus (types 6 and 11) L1 virus-like particle vaccine - Xiamen Innovax; Human papillomavirus 6/11 bivalent vaccine - Xiamen; Human papillomavirus 6/11 vaccine - Xiamen; Recombinant human papillomavirus type 6/11 bivalent vaccine - Xiamen Innovax

Latest Information Update: 28 Mar 2019

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Xiamen Innovax Biotech
  • Developer Beijing Wantai Bio-pharm; Xiamen Innovax Biotech; Xiamen University
  • Class Papillomavirus vaccines; Synthetic vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Condylomata acuminata

Most Recent Events

  • 28 Mar 2019 No recent reports of development identified for phase-I development in Condylomata-acuminata(Prevention, In volunteers) in China (IM)
  • 12 Mar 2016 Xiamen Innovax Biotech, Beijing Wantai Bio-pharm and Xiamen University plan a phase II trial for Condylomata acuminata (Prevention, In volunteers) in China (IM) (NCT02710851)
  • 01 Mar 2015 Preclinical trials in Condylomata acuminata in China (IM)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top